Furthermore, the neurotrophic factor prosaposin (PSAP), a conserved glycoprotein that promotes GBM migration/invasion and MES reprogramming via the TGF-β1/SMAD signaling pathway, has been reported as a novel targetable MES biomarker [155] (Figure 3). This evidence concerns the gene TGFB1 and glioblastoma.